[HTML][HTML] Renin–angiotensin–aldosterone-system inhibitors increase the serum level of complement component 4 in patients with immunoglobulin A nephropathy
M Mao, Y Zhou, X Zhang, XY Zhao, CD Wang… - International …, 2024 - Elsevier
Objective To investigate the impact of renin–angiotensin–aldosterone-system (RAAS)
inhibitors on complement component 4 (C4) serum levels in patients with immunoglobulin A …
inhibitors on complement component 4 (C4) serum levels in patients with immunoglobulin A …